Animal StudyPubMed ID: 17326080·2007

TB-500 Protects Against Acute Liver Injury

Craven RJ, Xu LH, Weiner TM, et al.

Hepatology, 2007 · n = 38

Key finding

TB-500 reduced transaminase elevation by 81%, decreased hepatocyte apoptosis by 73%, improved survival from 25% to 82%.

Summary

TB-500 protected hepatocytes from LPS and D-galactosamine-induced acute liver injury.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

More research on TB-500